Last reviewed · How we verify
JE Vaccine existing facility
JE Vaccine existing facility is a Vaccine Biologic drug developed by International Centre for Diarrhoeal Disease Research, Bangladesh. It is currently FDA-approved for Prevention of Japanese encephalitis in endemic regions.
JE Vaccine stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus.
JE Vaccine stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus. Used for Prevention of Japanese encephalitis in endemic regions.
At a glance
| Generic name | JE Vaccine existing facility |
|---|---|
| Sponsor | International Centre for Diarrhoeal Disease Research, Bangladesh |
| Drug class | Vaccine |
| Target | Japanese encephalitis virus envelope proteins |
| Modality | Biologic |
| Therapeutic area | Infectious Disease / Immunology |
| Phase | FDA-approved |
Mechanism of action
The vaccine contains inactivated Japanese encephalitis virus or viral antigens that trigger both humoral (antibody) and cell-mediated immune responses. This immunization provides protection against infection by the Japanese encephalitis virus, which is transmitted by Culex mosquitoes in endemic regions of Asia.
Approved indications
- Prevention of Japanese encephalitis in endemic regions
Common side effects
- Local injection site reactions (pain, erythema, swelling)
- Fever
- Headache
- Myalgia
- Fatigue
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- JE Vaccine existing facility CI brief — competitive landscape report
- JE Vaccine existing facility updates RSS · CI watch RSS
- International Centre for Diarrhoeal Disease Research, Bangladesh portfolio CI
Frequently asked questions about JE Vaccine existing facility
What is JE Vaccine existing facility?
How does JE Vaccine existing facility work?
What is JE Vaccine existing facility used for?
Who makes JE Vaccine existing facility?
What drug class is JE Vaccine existing facility in?
What development phase is JE Vaccine existing facility in?
What are the side effects of JE Vaccine existing facility?
What does JE Vaccine existing facility target?
Related
- Drug class: All Vaccine drugs
- Target: All drugs targeting Japanese encephalitis virus envelope proteins
- Manufacturer: International Centre for Diarrhoeal Disease Research, Bangladesh — full pipeline
- Therapeutic area: All drugs in Infectious Disease / Immunology
- Indication: Drugs for Prevention of Japanese encephalitis in endemic regions